6 Results for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Conference Proceeding
|
|
P03.13 Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and reduce response to immune-oncology treatmentsJournal for immunotherapy of cancer, 2020, Vol.8 (Suppl 2), p.A27-A27 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2020-ITOC7.52Full text available |
| 2 |
Material Type: Conference Proceeding
|
|
L2 In vivo live imaging of human T/B cell lymphoma cross-linking mediated by bispecific CD20-TCB antibodyJournal for immunotherapy of cancer, 2020, Vol.8 (Suppl 2), p.A1-A1 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2020-ITOC7.2Full text available |
| 3 |
Material Type: Conference Proceeding
|
|
P03.05 Deep spatial profiling of the immune landscape of MSI and MSS colorectal tumorsJournal for immunotherapy of cancer, 2020, Vol.8 (Suppl 2), p.A24-A24 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2020-ITOC7.45Full text available |
| 4 |
Material Type: Conference Proceeding
|
|
P08.03 Neoantigen cancer vaccine auguments anti CTLA-4 efficacyJournal for immunotherapy of cancer, 2021, Vol.9 (Suppl 1), p.A25-A26 [Peer Reviewed Journal]2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2021-ITOC8.47Full text available |
| 5 |
Material Type: Conference Proceeding
|
|
P01.03 Targeting diaclyglycerol kinase alpha and zeta by self delivering RNAi to optimize tlymphocytes for adoptive therapy of solid tumorsJournal for immunotherapy of cancer, 2021, Vol.9 (Suppl 1), p.A4-A4 [Peer Reviewed Journal]2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2021-ITOC8.7Full text available |
| 6 |
Material Type: Conference Proceeding
|
|
P03.14 Preclinical case study: patient-derived head and neck cancer xenograft on mice humanized with autologous immune cells, a model for personalized immuno-oncology researchJournal for immunotherapy of cancer, 2020, Vol.8 (Suppl 2), p.A27-A28 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2020-ITOC7.53Full text available |
Personalize your results
Refine Search Results
Expand My Results
Subject
- Tumors (3)
- Cancer (2)
- Lymphocytes (2)
- Motility (1)
- Oncology (1)
- Kinases (1)
- Immunotherapy (1)
- Pharmaceuticals (1)
- Vaccines (1)
- Pharmacology (1)
- Gene Expression (1)
- Case Studies (1)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||